.this website uses cookies. using this website means you are okay with this but you can find out more and learn how to manage your cookie choices., and bones, and it�s not clear how the drugs will affect them after long-term use...
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..